Active ingredient
Treprostinil
41 finished FDA listings contain Treprostinil as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TREPROSTINIL, TREPROSTINIL DIOLAMINE, TREPROSTINIL SODIUM
- Dosage forms
- Capsule, Inhalant, Injection, Injection, Solution, Tablet, Extended Release
- Routes
- Intravenous, Oral, Respiratory (Inhalation), Subcutaneous
- Manufacturers / labelers
- 6
- Strengths listed
- .125 mg/1 · .25 mg/1 · 1 mg/1 · 1.74 mg/2.9ml · 100 mg/20ml · 106 ug/1 · 16 ug/1 · 2.5 mg/1 · 20 mg/20ml · 200 mg/20ml · 26.5 ug/1 · 32 ug/1 · 48 ug/1 · 5 mg/1 · 50 mg/20ml · 53 ug/1 · 64 ug/1 · 79.5 ug/1 · 8 mg/20ml · 80 ug/1
- Brand names in FDA listings
- Orenitram, Remodulin, Tyvaso, Tyvaso Dpi, Yutrepia
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 343048
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 021272 | UNITED THERAP | 2002-05-21 | 5 |
| NDA 022387 | UNITED THERAP | 2009-07-30 | 1 |
| NDA 203496 | UNITED THERAP | 2013-12-20 | 5 |
| ANDA 203649 | SANDOZ | 2017-11-30 | 4 |
| ANDA 206648 | TEVA PHARMS USA | 2019-09-26 | 4 |
| ANDA 210214 | DR REDDYS | 2020-05-22 | 4 |
| ANDA 211574 | ALEMBIC GLOBAL | 2021-02-11 | 4 |
| NDA 214324 | UNITED THERAP | 2022-05-23 | 10 |
| NDA 213005 | LIQUIDIA TECH | 2025-05-23 | 4 |
Official labeling on DailyMed
- REMODULIN (TREPROSTINIL) INJECTION, SOLUTION STERILE DILUENT FOR REMODULIN (WATER) INJECTION, SOLUTION [UNITED THERAPEUTICS CORPORATION] · version 35 · 2026-07-20
- TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORPORATION] · version 32 · 2026-04-20
- TYVASO DPI (TREPROSTINIL) INHALANT TYVASO DPI (TREPROSTINIL) KIT [UNITED THERAPEUTICS CORPORATION] · version 14 · 2025-11-26
- YUTREPIA (TREPROSTINIL) CAPSULE [LIQUIDIA TECHNOLOGIES, INC.] · version 3 · 2025-09-10
- TREPROSTINIL INJECTION, SOLUTION [ALEMBIC PHARMACEUTICALS INC.] · version 8 · 2025-03-13
- ORENITRAM (TREPROSTINIL) TABLET, EXTENDED RELEASE ORENITRAM (TREPROSTINIL) KIT [UNITED THERAPEUTICS CORPORATION] · version 24 · 2024-12-06
- TREPROSTINIL INJECTION, SOLUTION STERILE DILUENT FOR TREPROSTINIL (WATER) INJECTION, SOLUTION [DR.REDDY'S LABORATORIES INC.,] · version 8 · 2024-08-02
- TREPROSTINIL INJECTION DILUENT (WATER SOLUTION) INJECTION [SANDOZ INC] · version 25 · 2023-09-13
- TREPROSTINIL INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] · version 5 · 2022-06-24
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.